Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India

Chang, 2015, Comprehensive analysis of the incidence and survival patterns of lung cancer by histologies, including rare subtypes, in the era of molecular medicine and targeted therapy, Medicine (Baltimore), 94, e969, 10.1097/MD.0000000000000969 Rossi, 2013, Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice, Cancer Treat Rev, 39, 498, 10.1016/j.ctrv.2012.09.006 Kelley, 2013, Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206, J Thorac Oncol, 8, 102, 10.1097/JTO.0b013e31827628e1 Chan, 2013, Chemotherapy advances in small-cell lung cancer, J Thorac Dis, 5, S565 Kalemkerian, 2014, Advances in pharmacotherapy of small cell lung cancer, Expert Opin Pharmacother, 15, 2385, 10.1517/14656566.2014.957180 Kanaji, 2014, Paraneoplastic syndromes associated with lung cancer, World J Clin Oncol, 5, 197, 10.5306/wjco.v5.i3.197 Quoix, 2008, Topotecan in the treatment of relapsed small cell lung cancer, OncoTargets Ther, 1, 79, 10.2147/OTT.S3689 Shi, 2015, Current small cell lung cancer treatment in China, Thorac Cancer, 6, 233, 10.1111/1759-7714.12218 Powell, 2014, Treatment decisions and survival for people with small-cell lung cancer, Br J Cancer, 110, 908, 10.1038/bjc.2013.812 Kuo, 2012, Survival of patients with small cell lung carcinoma in Taiwan, Oncology, 82, 19, 10.1159/000335084 Sobue, 1996, Epidemiology of lung cancer and prevention strategy in Japan, Nihon Eiseigaku Zasshi Jpn J Hyg, 51, 641, 10.1265/jjh.51.641 Dores, 2015, A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992–2010, BMC Cancer, 15, 185, 10.1186/s12885-015-1188-y Hermes, 2011, Characteristics, treatment patterns and outcomes of patients with small cell lung cancer – a retrospective single institution analysis, Lung Cancer, 71, 363, 10.1016/j.lungcan.2010.06.003 Slotman, 2007, Prophylactic cranial irradiation in extensive small-cell lung cancer, N Engl J Med, 357, 664, 10.1056/NEJMoa071780 Aupérin, 1999, Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group, N Engl J Med, 341, 476, 10.1056/NEJM199908123410703 Pignon, 1992, A meta-analysis of thoracic radiotherapy for small-cell lung cancer, N Engl J Med, 327, 1618, 10.1056/NEJM199212033272302 Fried, 2004, Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer, J Clin Oncol, 22, 4837, 10.1200/JCO.2004.01.178 Kubota, 2014, Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study, Lancet Oncol, 15, 106, 10.1016/S1470-2045(13)70511-4 Xiao, 2015, Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer, OncoTargets Ther, 8, 2209, 10.2147/OTT.S89606 Ha, 2013, Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer, J Radiat Oncol, 31, 185, 10.3857/roj.2013.31.4.185 Zhu, 2013, Treatment modality selection and prognosis of early stage small cell lung cancer: retrospective analysis from a single cancer institute, Eur J Canc Care (Engl), 22, 789, 10.1111/ecc.12082 Scotti, 2012, Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy, Tumori, 98, 53, 10.1177/030089161209800107